Stay abreast of the latest life sciences applications of AI at: 

“GenAI Roadmap: Transforming the Future of Healthcare & Life Sciences” 

October 9, 2025 

State Room, Boston 

At this interactive event, Amazon Web Services (AWS) partner organizations will explore how GenAI is reshaping the future of health — from bench to bedside. 

Tobi Guennel, Ph.D., QuartzBio’s Chief Technology Officer, will present use cases showing how R&D organizations are leveraging agentic frameworks and multi-agent networks to scale GenAI’s impact on every aspect of precision medicine development. 

View the full agenda and speaker lineup: https://www.aws-partner-events.com/gen-ai-conference-healthcare-and-lifesciences/ 

Register Now
You might also like
QuartzBio AI Agents Reshape Precision MedicineThe Dawn of the Frontier Firm: How AI Agents Are Reshaping Work & Precision Medicine
QuartzBio Logo_The Precision Medicine Intelligence Company _white

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.

© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR

Web Design and Development by RainCastle Communications.